BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180319
DTEND;VALUE=DATE:20180321
DTSTAMP:20260515T083507
CREATED:20171023T082959Z
LAST-MODIFIED:20171023T084059Z
UID:3576-1521417600-1521590399@www.pharmajournalist.com
SUMMARY:20th Annual Superbugs & Superdrugs
DESCRIPTION:Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities\, SMi presents the 20th annual Superbugs &Superdrugs conference which will return to Central London on 19th and 20th March 2018. \nThe threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders\, drug discovery specialists and government bodies such as MHRA and DNDi. \nFEATURED SPEAKERS INCLUDE: \n– Richard Bax\, Senior Partner\, TranScrip Partners\n– Lloyd Czaplewski\, Director\, Chemical Biology Ventures\n– Mair Powell\, Senior clinical assessor\, MHRA\n– Jean-Pierre Paccaud\, Director of Business Development at GARDP\, Drugs for Neglected Diseases initiative (DNDi)\n– Conrad Lichtenstein\, CSO\, Nemesis bioscience\n– David Brown\, Managing Director and Founder\, Alchemy Biomedical Consulting\n– Domingo Gargallo-Viola\, Chief Scientific Officer\, ABAC Therapeutics\n– John George\, CSO\, Oppilotech\n– Larry Sutton\, Scientific Founder\, Gladius Pharmaceuticals\n– Kathy Talkington\, Project Director\, Pew charitable trusts\n– David Cook\, Chief Scientific Officer\, Blueberry Therapeutics\n– William Weiss\, Director of Pre-Clinical Services\, University of North Texas Health Science Center\n– Cara Cassino\, Chief Medical Officer\, ContraFect\n– Stephen Barat\, Head of Pre-Clinical and Early Clinical Development\, SCYNEXIS Inc \nWHATS ON THE AGENDA FOR 2018? \n– Analyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR\n– Hear exclusive case studies from a selection of pharmaceutical companies on clinical progress\n– Learn about regulatory pathways for the registration of new antimicrobial agents\n– Evaluate the latest incentives and funding solutions to spur drug discovery\n– Explore novel alternatives to antibiotics currently in development \nTo register visit www.superbugssuperdrugs.com/pjournalist \nFor enquires contact the team on +44 (0)207 827 6000 or email events@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/20th-annual-superbugs-superdrugs/
LOCATION:Copthorne Tara Hotel\, Kensington\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:events@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180319
DTEND;VALUE=DATE:20180321
DTSTAMP:20260515T083507
CREATED:20171031T010129Z
LAST-MODIFIED:20171031T044056Z
UID:3637-1521417600-1521590399@www.pharmajournalist.com
SUMMARY:12th annual Paediatric Clinical
DESCRIPTION:SMi is pleased to present the return of their 12th annual Paediatric Clinical Trials Conference taking place on 19th – 20th March 2018\, London\, UK. \n \nClinical trials in paediatric populations still pose several challenges and often many studies remain un- published. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children. Recent advancements in immuno-oncology research has led to an increase in clinical trials to treat cancer in children and adolescents. Greater emphasis has also been placed on pain-free administration of drugs in the bid to increase vaccination uptake and access to medicines. \nJoin us as we discuss current clinical trials and the innovative digital technology being used to improve clinical recruitment and retention as well as improve the quality of data being collected. leading industry experts will be looking at how to work within regulations and foster the involvement of young people in their care. We will also be looking at the planning and executing a paediatric clinical trial and the ways this can vary according to region. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints. \nReasons to attend Paediatric Clinical Trials 2018 \n– Regulatory keynote from the MHRA – The UK’s Early Access to Medicines Scheme (EAMS) and how this scheme benefits paediatric patients\n– Hear from Amgen and Roche as they give exclusive case studies on new approaches to recruitment\, retention\, and clinical trial design for rare diseases\n– Pfizer and Barcelona Children’s Hospital will be exploring how advancements in technology are facilitating improved clinical trials and data collection for paediatric drug development\n– AstraZeneca will be reviewing and discussing paediatric clinical trial Legislation in the EU and US.\n– There will be an exciting panel with the likes of GSK\, Roche and regulatory bodies debating challenges and opportunities 10 years on from paediatric regulation in the EU and potential changes on the horizon\n– There will be multiple pharmaceutical companies (UCB\, Sanofi and GSK) debating scenarios where data extrapolation and government incentives might increase access to medicines in paediatric populations.\n– Discover how to optimise your approach to clinical success through global collaboration being discussed by Takeda
URL:https://www.pharmajournalist.com/event/12th-annual-paediatric-clinical/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:kwilliams@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180320
DTEND;VALUE=DATE:20180322
DTSTAMP:20260515T083507
CREATED:20171204T074612Z
LAST-MODIFIED:20171204T074612Z
UID:4963-1521504000-1521676799@www.pharmajournalist.com
SUMMARY:7th Annual Clinical Data Integration & Management
DESCRIPTION:After the most successful Clinical Data Integration & Management conference to date\, we are excited to announce Arena International will be returning to Princeton in March 2018 for another epic event. \n \nThis year we brought together over 100 senior level professionals working within clinical data management to network and overcome some of the biggest challenges facing the industry. \nA highlight of our 2017 programme included an interactive panel discussion on the first day\, exploring how to achieve the right balance between increasing the data delivery speed whilst continuing to produce high quality data. Attendees had the opportunity to ask our 3 industry experts probing questions to uncover potential solutions to this challenge. \nDay 2 saw an engaging presentation from Johnson & Johnson\, addressing the wearable technologies currently being incorporated into clinical trials. They highlighted various examples of wearables as well as recognizing the challenges with moving towards these advanced technologies. This presentation was followed by a Q&A\, opening up the discussion to the audience. \nNext year’s ECDM event will be even better with more interactive sessions and content. We look forward to seeing you in Princeton next March! \nTo learn more about this event\, and to register online\, visit www.arena-international.com/ecdm/
URL:https://www.pharmajournalist.com/event/7th-annual-clinical-data-integration-management/
LOCATION:Princeton\,NJ
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180320
DTEND;VALUE=DATE:20180322
DTSTAMP:20260515T083507
CREATED:20171214T080104Z
LAST-MODIFIED:20171214T080104Z
UID:5339-1521504000-1521676799@www.pharmajournalist.com
SUMMARY:PHARMA SECURITY WORLD 2018
DESCRIPTION:The Counterfeit medicines are turning into a serious concern around the world\, and have progressively been showing up through the real pharmaceutical supply chain\, including community and online drug stores. What’s more\, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue\, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security World 2018 – An Anti-counterfeiting & Brand Safety Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2o5HD1M
URL:https://www.pharmajournalist.com/event/pharma-security-world-2018/
LOCATION:London\, UK
ORGANIZER;CN="Corvus Global Events Limited":MAILTO:info@corvusglobalevents.com/ fazmina@corvusglobalevents.com
END:VEVENT
END:VCALENDAR